Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection

DOI Web Site 3 Citations
  • Najmeh Bozorgmehr
    School of Dentistry, Division of Foundational Sciences, University of Alberta, Edmonton, Alberta, Canada
  • Siavash Mashhouri
    School of Dentistry, Division of Foundational Sciences, University of Alberta, Edmonton, Alberta, Canada
  • Eliana Perez Rosero
    School of Dentistry, Division of Foundational Sciences, University of Alberta, Edmonton, Alberta, Canada
  • Lai Xu
    School of Dentistry, Division of Foundational Sciences, University of Alberta, Edmonton, Alberta, Canada
  • Shima Shahbaz
    School of Dentistry, Division of Foundational Sciences, University of Alberta, Edmonton, Alberta, Canada
  • Wendy Sligl
    Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
  • Mohammed Osman
    Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
  • Demetrios J. Kutsogiannis
    Department of Critical Care Medicine, University of Alberta, Edmonton, Alberta, Canada
  • Erika MacIntyre
    Misericordia Community Hospital, Edmonton, Alberta, Canada
  • Conar R. O’Neil
    Division of Infectious Diseases, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada
  • Shokrollah Elahi
    School of Dentistry, Division of Foundational Sciences, University of Alberta, Edmonton, Alberta, Canada
  • Dimitrios Paraskevis
    editor

Abstract

<jats:p>The outbreak of SARS-CoV-2 infection has enormously impacted our lives. Clinical evidence has implicated the emergence of cytokine release syndrome as the prominent cause of mortality in COVID-19 patients.</jats:p>

Journal

  • mBio

    mBio 12 (3), e00384-21-, 2021-06-29

    American Society for Microbiology

Citations (3)*help

See more

Details 詳細情報について

Report a problem

Back to top